BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8200360)

  • 21. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
    Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
    AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
    Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
    J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical and pathologic study of 34 sarcomas of the uterus.
    Kenda R; De Palo G; Andreola S; Bandieramonte G; Lupi G; Musumeci R
    Tumori; 1981 Aug; 67(4):341-8. PubMed ID: 7314262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and treatment modalities in uterine sarcoma.
    El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
    Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of patients with sarcoma of the uterus.
    Bokhman JV; Yakovleva IA; Urmanchejeva AF
    Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
    Tinkler SD; Cowie VJ
    Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980.
    De Fusco PA; Gaffey TA; Malkasian GD; Long HJ; Cha SS
    Gynecol Oncol; 1989 Oct; 35(1):8-14. PubMed ID: 2792908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
    Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
    Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.
    Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R
    Oncology; 2004; 67(1):33-9. PubMed ID: 15459493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of uterine sarcomas.
    Echt G; Jepson J; Steel J; Langholz B; Luxton G; Hernandez W; Astrahan M; Petrovich Z
    Cancer; 1990 Jul; 66(1):35-9. PubMed ID: 2354406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on treatment of uterine sarcoma.
    Nam JH; Park JY
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
    Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
    Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine sarcoma: a clinicopathological study of 93 cases.
    González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
    Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.